Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Gross PP&E Adjustments: 2019-2023

Historic Other Gross PP&E Adjustments for ADC Therapeutics (ADCT) over the last 5 years, with Sep 2023 value amounting to $4.1 billion.

  • ADC Therapeutics' Other Gross PP&E Adjustments rose 195.97% to $4.1 billion in Q3 2023 from the same period last year, while for Sep 2023 it was $18.2 billion, marking a year-over-year decrease of 19.79%. This contributed to the annual value of -$15.8 million for FY2022, which is 4.74% up from last year.
  • As of Q3 2023, ADC Therapeutics' Other Gross PP&E Adjustments stood at $4.1 billion, which was up 37,843.98% from -$11.0 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Other Gross PP&E Adjustments ranged from a high of $27.0 billion in Q4 2021 and a low of -$4.3 billion during Q3 2022.
  • Over the past 3 years, ADC Therapeutics' median Other Gross PP&E Adjustments value was -$7.6 million (recorded in 2021), while the average stood at $3.7 billion.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 66,470.26% in 2021, then soared by 195.97% in 2023.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Other Gross PP&E Adjustments stood at -$5,256 in 2019, then tumbled by 5,901.59% to -$11,343 in 2020, then crashed by 66,470.26% to $27.0 billion in 2021, then tumbled by 47.89% to $14.1 billion in 2022, then spiked by 195.97% to $4.1 billion in 2023.
  • Its Other Gross PP&E Adjustments stands at $4.1 billion for Q3 2023, versus -$11.0 million for Q2 2023 and -$11.2 million for Q1 2023.